Sialyl-Tn in Cancer: (How) Did We Miss the Target?

http://www.mdpi.com/2218-273X/2/4/435

Detalhes bibliográficos
Autor principal: Sylvain , Julien (author)
Outros Autores: Videira, Paula A (author), Delannoy, Philippe (author)
Formato: article
Idioma:eng
Publicado em: 2017
Assuntos:
ST6GalNAc I
cancer immunotherapy
Theratope
O-glycan
Sialyl-Tn antigen
SDG 3 - Good Health and Well-being
Texto completo:https://doi.org/10.3390/biom2040435
País:Portugal
Oai:oai:run.unl.pt:10362/23346
Descrição
Resumo:http://www.mdpi.com/2218-273X/2/4/435

Registros relacionados